Hexal AG
Records under this name other than the patents Hexal AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,895,497 | Method for reducing leachables and extractables in syringes Lapsed on the fee record Ended Feb 20, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2026 | From the USPTO record |
| US 9,844,515 | Transdermal therapeutic system comprising buprenorphine Lapsed on the fee record Ended Dec 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 19, 2025 | From the USPTO record |
| US 9,789,112 | Oral pharmaceutical film formulation for bitter tasting drugs Lapsed on the fee record Ended Oct 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2025 | From the USPTO record |
| US 9,717,707 | Pharmaceutical statin composition Lapsed on the fee record Ended Aug 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | From the USPTO record |
| US 11,072,605 | Crystalline brexpiprazole Lapsed on the fee record Ended Jul 27, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 27, 2025 | From the USPTO record |
| US 11,021,530 | Antibody preparation Lapsed on the fee record Ended Jun 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 1, 2025 | From the USPTO record |
| US D636,882 | Covering material Term ended Term ended Apr 26, 2025 · From the USPTO record | Term ended | Term ended Apr 26, 2025 | From the USPTO record |
| US 10,961,235 | Crystalline Form of Masitinib Formerly held Lapsed on the fee record Ended Mar 30, 2025 · High confidence | Lapsed on the fee record | Ended Mar 30, 2025 | High confidence |
| US D634,850 | Covering material Term ended Term ended Mar 22, 2025 · From the USPTO record | Term ended | Term ended Mar 22, 2025 | From the USPTO record |
| US 9,592,296 | Pharmaceutical composition for oral administration with a statin Lapsed on the fee record Ended Mar 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 14, 2025 | From the USPTO record |